« Guest Commentary: Dialysis Industry Consolidation Stagnates Technological Innovation | Main | First Do no Harm: The Living Renal Donor Dilemma - Dr. Brenda Mayne's Story »

Tuesday, January 10, 2012

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

John Agar

In a word .. Yes.

I think Peter Kerr's response to the nocturnal arm of the FHN trial in Nature Reviews Nephrology ... not 'titled', I might add, by Peter, and thus the title does not reflect the true intention of his comments ... says it all.

I have also previously made my views of RCTs in dialysis known in NNI a couple of years ago.

Between the two of us ... enough said to convey the view of we Australians.

We aren't impressed.

The comments to this entry are closed.

My Photo

October 2020

Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31